Adherence To The Inhaled Antibiotic Treatment In Patients With Cystic Fibrosis

被引：0
作者：
Sole, A. [1 ]
Gartner, S. [2 ]
Alvarez, A. [2 ]
Pastor, M. [3 ]
Baranda, F. [4 ]
Giron, R. [5 ]
Martinez, M. [6 ]
Prados, C. [7 ]
Maiz, L. [8 ]
Oliva, C. [9 ]
Gonzalez, M. [10 ]
机构：
[1] Univ Hosp La Fe, Valencia, Spain
[2] Vall dHebron Univ Hosp, Barcelona, Spain
[3] Virgen de la Arrixaca Univ Hosp, Murcia, Spain
[4] Cruces Univ Hosp, Baracaldo, Spain
[5] La Princesa Univ Hosp, Madrid, Spain
[6] 12 Octubre Univ Hosp, Madrid, Spain
[7] La Paz Univ Hosp, Madrid, Spain
[8] Ramon y Cajal Univ Hosp, Madrid, Spain
[9] Virgen Candelaria Univ Hosp, San Cristobal la Laguna, Spain
[10] Nino Jesus Hosp, Madrid, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4358
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PREDICTORS OF RESPONSE TO ANTIBIOTIC TREATMENT OF PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS
    Ratjen, F.
    Stanojevic, S.
    Sonneveld, N.
    Grasemann, H.
    Yau, Y.
    Tullis, E.
    Wilcox, P. G.
    Freitag, A.
    Chilvers, M.
    Waters, V. J.
    [J]. PEDIATRIC PULMONOLOGY, 2014, 49 : 355 - 355
  • [42] Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence"
    Hoo, Zhe Hui
    Curley, Rachael
    Campbell, Michael J.
    Walters, Stephen J.
    Hind, Daniel
    Wildman, Martin J.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 887 - +
  • [43] INHALED CEPHALORIDINE IN THE TREATMENT OF CYSTIC-FIBROSIS (CF)
    NOLAN, G
    MCIVOR, P
    GOLD, R
    NEWTH, C
    LEVISON, H
    COREY, M
    [J]. PEDIATRIC RESEARCH, 1981, 15 (04) : 618 - 618
  • [44] INHALED CEPHALORIDINE IN THE TREATMENT OF CYSTIC-FIBROSIS (CF)
    NOLAN, G
    MCIVOR, P
    GOLD, R
    NEWTH, C
    LEVISON, H
    COREY, M
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1981, 137 (01) : 122 - 122
  • [45] Nebulizer choice for inhaled colistin treatment in cystic fibrosis
    Katz, SL
    Ho, SL
    Coates, AL
    [J]. CHEST, 2001, 119 (01) : 250 - 255
  • [46] WHICH CYSTIC FIBROSIS INHALED ANTIBIOTIC MEDICINE FEATURES MATTER MOST TO ADULT PATIENTS AND PARENTS OF PEDIATRIC PATIENTS?
    Mohamed, A. F.
    Johnson, F. R.
    Balp, M. M.
    Calado, F.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A722 - A722
  • [47] Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis poor adherence and the need to address it
    Duff, Alistair J. A.
    Latchford, Gary J.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (06) : 455 - 456
  • [48] ANTIBIOTIC-TREATMENT OF CYSTIC-FIBROSIS
    MARINO, JT
    [J]. JOURNAL OF PEDIATRICS, 1981, 98 (03) : 511 - 511
  • [49] IMPROVING INHALED ANTIBIOTIC ADHERENCE
    Guthrie, C. P.
    Garza, E.
    Sadler, T.
    Dangerfield, M.
    Ackley, C.
    Allen, K.
    Couch, L.
    [J]. PEDIATRIC PULMONOLOGY, 2018, 53 : 378 - 378
  • [50] Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis
    White, Helen
    Shaw, Nicola
    Denman, Sarah
    Pollard, Kim
    Wynne, Sarah
    Peckham, Daniel Gavin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
12345